Altimmune, Inc.'s (ALT) CEO Vipin Garg on Q3 2021 Results - Earnings Call Transcript

Altimmune, Inc. (NASDAQ:ALT) Q3 2021 Earnings Conference Call November 10, 2021 8:30 AM ET

Company Participants

Will Brown – Chief Financial Officer
Vipin Garg – Chief Executive Officer
Scot Roberts – Scientific Officer
Scott Harris – Chief Medical Officer

Conference Call Participants

Seamus Fernandez – Guggenheim
Yasmeen Rahimi – Piper Sandler
Liisa Bayko – Evercore ISI
Jon Wolleben – JMP Securities
Mayank Mamtani – B. Riley Securities
Patrick Trucchio – HC Wainwright

Operator

Good day, ladies and gentlemen, and welcome to the Altimmune, Inc. Q3 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this call may be recorded.

I would now like to introduce your host for today's conference call, Will Brown, Chief Financial Officer of Altimmune. Will, you may begin.

Will Brown

Thank you, operator, and good morning, everyone. Thank you for participating in Altimmune's third quarter 2021 earnings conference call. Members of the Altimmune team joining me on the call today are Vipin Garg, our Chief Executive Officer; Scot Roberts, our Chief Scientific Officer; and Scott Harris, our Chief Medical Officer. Following the prepared remarks, we will hold a question-and-answer session. A press release with our third quarter, 2021 financial results was issued last night and can be found on the IR section of the Company's website.

Before we begin, I would like to remind everyone the remarks about future expectations, plans, and prospects constitute forward-looking statements for purposes of Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995.

Altimmune cautions that these forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those indicated, including those related to COVID-19 and its impact on our